Cardiac Arrhythmias
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements Patient is intended to be treated with, an eligible Medtronic product
Exclusion criteria
Exclusion criteria: Patient who is, or is expected to be, inaccessible for follow-up Patient is currently enrolled in, or plans to enroll in, any concurrent drug/device study that may confound the PSR results (i.e., no required intervention that could affect interpretation of all-around product safety and/or effectiveness)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The acute major complication rate related to the Micra AV system and/or procedure | — |
Secondary
| Measure | Time frame |
|---|---|
| The 1-year major complication rate related to the Micra AV system and/or procedure %AM-VP in patients with greater than 90% ventricular pacing and a primary pacing indication of 3rd degree AV block | — |
Contacts
Medtronic Japan